ChromaDex Initiates Second Human Clinical Study for its Caffeine Ingredient, PURENERGY
date:May 15, 2014
uman study, which was performed in the summer of 2013. The new clinical trial will study the bioavailability and pharmacokinetics of PURENERGY as compared to caffeine and pTeroPure pterostilbene alone at repeated doses.

PURENERGY is an innovative patented caffeine ingredient that is a cocrystal combination of caffeine and ChromaDex's patented pTeroPure pterostilbene. The combination forms a unique crystalline structure that has superior benefits as compared to caffeine alone. Recently, caffeina
2/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/12 08:54